Departments, Centers, & Programs:
Infectious Disease Associates
55 Fruit Street
Boston, MA 02114-2696
- MD, Harvard Medical School
- Residency, Massachusetts General Hospital
- Fellowship, Massachusetts General Hospital
American Board Certifications
- Internal Medicine, American Board of Internal Medicine
- Infectious Disease, American Board of Internal Medicine
Accepted Insurance Plans
Note: This provider may accept more insurance plans than shown; please call the practice to find out if your plan is accepted.
My research interests are related to hepatitis C virus (HCV) infection in special populations. I have three primary areas of focus:
1. HCV in immunosuppressed humans, including coinfection with HIV-1 and post-transplantation. My interests are in cell-mediated immunity and HCV viral evolution in collaboration with Georg Lauer, Todd Allen
2. Immunology of acute HCV, in collaboration with Georg Lauer of the Gastrointestinal Unit
3. Acute HCV in the MA prisons. As project leader of a U19 NIH Center Grant, I am studying acute HCV in the Massachusetts State Prisons in collaboration with Barbara McGovern at the Lemuel Shattuck Hospital and the Department of Public Health
4. Immunogenetics of HCV infection, in collaboration with Georg Lauer, Ray Chung of the Gastrointestinal Unit, and Mark Daly of the Broad Institute
Selected from 91 publications in Pubmed
- Kim AY, Lauer GM, Ouchi K, et al. The magnitude and breadth of hepatitis C virus-specific CD8+ T cells depend on absolute CD4+ T cell count in individuals coinfected with HIV-1. Blood. 2005;105(3):1170-1178.
- Kim AY, Schulze zur Wiesch J, Kuntzen T, et al. Impaired HCV-specific T cell responses and recurrent HCV in HIV coinfection. PLoS Med. 2006;3(12):e492.
- Kim AY, Kuntzen T, Timm J, et al. Spontaneous control of HCV is associated with the expression of HLA-B*57 and preservation of targeted epitopes. Gastroenterology 2011; 140(2):686-696.
- Kim AY, Nagami EH, Birch CE, et al. A simple strategy to identify acute hepatitis C infection among newly incarcerated injection drug users. Hepatology 2013; 57(3):944-52.
- Kim AY, Onofrey S, Church DR. An epidemiologic update on hepatitis C infection in persons living with or at risk of HIV infection. Journal of Infectious Diseases 2013;207 Suppl 1:S1-6.
- Onofrey S, Aneja J, Haney GA, et al. Underascertainment of acute hepatitis C infections in the U.S. surveillance system: implications for incidence estimates. Annals of Internal Medicine 2015;163(4):254-61.